KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism

Cell Reports
Erhu ZhaoHan-Fei Ding

Abstract

The histone lysine demethylase KDM4C is often overexpressed in cancers primarily through gene amplification. The molecular mechanisms of KDM4C action in tumorigenesis are not well defined. Here, we report that KDM4C transcriptionally activates amino acid biosynthesis and transport, leading to a significant increase in intracellular amino acid levels. Examination of the serine-glycine synthesis pathway reveals that KDM4C epigenetically activates the pathway genes under steady-state and serine deprivation conditions by removing the repressive histone modification H3 lysine 9 (H3K9) trimethylation. This action of KDM4C requires ATF4, a transcriptional master regulator of amino acid metabolism and stress responses. KDM4C activates ATF4 transcription and interacts with ATF4 to target serine pathway genes for transcriptional activation. We further present evidence for KDM4C in transcriptional coordination of amino acid metabolism and cell proliferation. These findings suggest a molecular mechanism linking KDM4C-mediated H3K9 demethylation and ATF4-mediated transactivation in reprogramming amino acid metabolism for cancer cell proliferation.

References

Apr 19, 2002·The Journal of Biological Chemistry·Fai SiuMichael S Kilberg
Jul 26, 2003·The Biochemical Journal·Russell HydeHarinder S Hundal
Sep 4, 2003·Genome Research·Paul D ThomasApurva Narechania
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
May 1, 2007·The International Journal of Biochemistry & Cell Biology·Kurosh Ameri, Adrian L Harris
Jan 8, 2008·Cell Metabolism·Ralph J DeBerardinisCraig B Thompson
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ursula VinatzerBerthold Streubel
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Aug 20, 2009·Diabetes·Jin SeoJonathan M Graff
Oct 6, 2009·Trends in Endocrinology and Metabolism : TEM·Michael S KilbergNan Su
Apr 9, 2010·Annual Review of Biochemistry·Nima Mosammaparast, Yang Shi
Dec 16, 2010·Cancer Cell·Lixin RuiLouis M Staudt
Jan 25, 2011·Nature Reviews. Cancer·Rob A CairnsTak W Mak
Apr 19, 2011·Genes & Development·Yoichi Shinkai, Makoto Tachibana
May 10, 2011·Annual Review of Biochemistry·Joungmok Kim, Kun-Liang Guan
Aug 2, 2011·Nature Genetics·Jason W LocasaleMatthew G Vander Heiden
Sep 13, 2011·Cell Metabolism·Ralph J DeBerardinis
Jan 24, 2012·Cell·Sayako KatadaPaolo Sassone-Corsi
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
Apr 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jiangbin YeCraig B Thompson
May 9, 2012·The Journal of Biological Chemistry·Satish C Kalhan, Richard W Hanson
May 16, 2012·Advances in Nutrition·Thomas D Baird, Ronald C Wek
Jul 10, 2012·Cell Metabolism·Chao Lu, Craig B Thompson
Dec 4, 2012·Molecular Cell·Joshua C BlackJohnathan R Whetstine
Apr 2, 2013·Cell·William G Kaelin, Steven L McKnight
May 7, 2013·Cancer Research·William L Berry, Ralf Janknecht
Jul 5, 2013·Nature Reviews. Cancer·Jason W Locasale
Jul 12, 2013·Nature Reviews. Cancer·Subhashini Sadasivam, James A DeCaprio
Jan 8, 2014·Molecular and Cellular Biology·Marianne Terndrup PedersenKristian Helin
Mar 25, 2014·Trends in Biochemical Sciences·Ivano AmelioGerry Melino
May 9, 2014·Nature·Jing FanJoshua D Rabinowitz
May 13, 2014·Cell Reports·Christiaan F LabuschagneOliver D K Maddocks

❮ Previous
Next ❯

Citations

Sep 17, 2016·Nature Reviews. Cancer·Ming Yang, Karen H Vousden
Oct 5, 2016·Molecular Aspects of Medicine·Hanah RodriguezAssam El-Osta
Apr 20, 2018·The Journal of Pathology·Laurie K SvobodaElizabeth R Lawlor
Oct 3, 2018·ELife·Justin RendlemanChristine Vogel
Oct 28, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chao YinHongjuan Cui
Nov 7, 2019·The Journal of Cell Biology·Miguel Reina-CamposJorge Moscat
Aug 7, 2018·Clinical Nutrition Research·HaEun Kim, Yoon Jung Park
Apr 23, 2020·Cellular and Molecular Life Sciences : CMLS·Zhenhua Yang, Hao Jiang
Mar 20, 2020·Nutrition & Metabolism·Jian-Sheng Kang
Aug 23, 2019·World Journal of Gastrointestinal Oncology·Si-Si LiRong Wan
Mar 15, 2019·Scientific Reports·Nir GonenReut Shalgi
Aug 18, 2020·Progress in Neurobiology·Marianne MaugardGilles Bonvento
Jan 30, 2021·Frontiers in Cell and Developmental Biology·Zhen WeiPing Yi
Jan 30, 2021·Nature Metabolism·Shauni L GeeraertsKim R Kampen
Apr 9, 2020·Cell Metabolism·Robert T WilliamsKıvanç Birsoy
Jun 24, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sarder ArifuzzamanRabeya Khatun
Aug 28, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Justin EnglishValentina Perissi
Apr 4, 2021·Cancers·Anaís Sánchez-CastilloKim R Kampen
Apr 30, 2021·Frontiers in Cell and Developmental Biology·Longchang BaiHongjuan Cui
May 6, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Li ChenMao Chen
May 21, 2021·Biochemical and Biophysical Research Communications·Xingquan ZhouXu Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.